Calian Group Ltd. (TSE:CGY – Get Free Report) insider Patrick Belanger Houston bought 699 shares of the stock in a transaction that occurred on Friday, August 28th. The shares were purchased at an average cost of C$73.18 per share, with a total value of C$51,152.82. Following the purchase, the insider directly owned 22,965 shares of the company’s stock, valued at C$1,680,578.70. The trade was a 3.14% increase in their ownership of the stock.
Calian Group Price Performance
CGY stock opened at C$74.52 on Tuesday. The company has a quick ratio of 1.20, a current ratio of 1.61 and a debt-to-equity ratio of 54.28. The firm has a market cap of C$857.87 million, a price-to-earnings ratio of 22.58, a PEG ratio of 2.50 and a beta of 0.96. The company’s fifty day simple moving average is C$80.57 and its 200 day simple moving average is C$78.46. Calian Group Ltd. has a 12-month low of C$44.89 and a 12-month high of C$95.50.
Calian Group (TSE:CGY – Get Free Report) last issued its quarterly earnings results on Thursday, August 13th. The company reported C$1.10 earnings per share for the quarter. Calian Group had a return on equity of 11.67% and a net margin of 4.41%.The firm had revenue of C$230.40 million during the quarter. On average, analysts expect that Calian Group Ltd. will post 4.9475219 earnings per share for the current year.
Calian Group Dividend Announcement
Analysts Set New Price Targets
CGY has been the topic of several recent analyst reports. Royal Bank Of Canada boosted their price target on Calian Group from C$90.00 to C$105.00 and gave the company an “outperform” rating in a research note on Friday, August 14th. Canadian Imperial Bank of Commerce lifted their price objective on shares of Calian Group from C$93.00 to C$107.00 in a research note on Friday, August 14th. Stifel Nicolaus set a C$100.00 target price on shares of Calian Group and gave the stock a “buy” rating in a research note on Wednesday, May 20th. Canaccord Genuity Group raised their price target on shares of Calian Group from C$103.00 to C$105.00 and gave the stock a “buy” rating in a report on Monday, June 29th. Finally, Desjardins raised their price target on shares of Calian Group from C$104.00 to C$109.00 and gave the stock a “buy” rating in a report on Friday, August 14th. Nine analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and an average price target of C$101.72.
Get Our Latest Report on Calian Group
About Calian Group
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
Featured Stories
- Five stocks we like better than Calian Group
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
